1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL PROTEOMICS MARKET BY TECHNOLOGY
5.1. Introduction
5.2. Microarrays
5.3. Spectroscopy
5.4. X-Ray Crystallography
5.5. Chromatography
5.6. Others
6. GLOBAL PROTEOMICS MARKET BY COMPONENT
6.1. Introduction
6.2. Reagents & Kits
6.3. Consumables
6.4. Others
7. GLOBAL PROTEOMICS MARKET BY REAGENTS
7.1. Introduction
7.2. Microarrays Reagents
7.3. Spectroscopy Reagents
7.4. X-Ray Crystallography Reagents
7.5. Chromatography Reagents
7.6. Other Reagents
8. GLOBAL PROTEOMICS MARKET BY APPLICATION
8.1. Introduction
8.2. Discovery of Protein Biomarkers
8.3. Study of Tumor Metastasis
8.4. Neurotrauma and Neurology
8.5. Renal Disease Diagnosis
8.6. Fetal and Maternal Medicine
8.7. Others
9. GLOBAL PROTEOMICS MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. United States
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Others
9.5. Middle East & Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. Japan
9.6.3. South Korea
9.6.4. India
9.6.5. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Biognosys AG
11.2. Creative Proteomics (Division of Creative Dynamics Inc)
11.3. Proteomics International
11.4. MRM Proteomics
11.5. Evotec AG
11.6. Proteome Factory
11.7. DC Biosciences
11.8. AYOXXA Biosystems GmbH
11.9. VProteomics
11.10. Thermo Fisher Scientific
11.11. Agilent Technologies
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES